554 related articles for article (PubMed ID: 25661015)
1. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
[TBL] [Abstract][Full Text] [Related]
2. [Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
Xie XF; Zhan Y; Ye YH; Li C; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):278-82. PubMed ID: 20646540
[TBL] [Abstract][Full Text] [Related]
3. Mif-deficiency favors an atheroprotective autoantibody phenotype in atherosclerosis.
Schmitz C; Noels H; El Bounkari O; Straussfeld E; Megens RTA; Sternkopf M; Alampour-Rajabi S; Krammer C; Tilstam PV; Gerdes N; Bürger C; Kapurniotu A; Bucala R; Jankowski J; Weber C; Bernhagen J
FASEB J; 2018 Aug; 32(8):4428-4443. PubMed ID: 29543531
[TBL] [Abstract][Full Text] [Related]
4. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
7. Targetted inhibition of CD74 attenuates adipose COX-2-MIF-mediated M1 macrophage polarization and retards obesity-related adipose tissue inflammation and insulin resistance.
Chan PC; Wu TN; Chen YC; Lu CH; Wabitsch M; Tian YF; Hsieh PS
Clin Sci (Lond); 2018 Jul; 132(14):1581-1596. PubMed ID: 29773671
[TBL] [Abstract][Full Text] [Related]
8. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
9. Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic mice.
Krammer C; Yang B; Reichl S; Besson-Girard S; Ji H; Bolini V; Schulte C; Noels H; Schlepckow K; Jocher G; Werner G; Willem M; El Bounkari O; Kapurniotu A; Gokce O; Weber C; Mohanta S; Bernhagen J
FASEB J; 2023 Mar; 37(3):e22752. PubMed ID: 36794636
[TBL] [Abstract][Full Text] [Related]
10. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
11. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y
Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
13. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
[TBL] [Abstract][Full Text] [Related]
14. Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
Burger-Kentischer A; Göbel H; Kleemann R; Zernecke A; Bucala R; Leng L; Finkelmeier D; Geiger G; Schaefer HE; Schober A; Weber C; Brunner H; Rütten H; Ihling C; Bernhagen J
Atherosclerosis; 2006 Jan; 184(1):28-38. PubMed ID: 15921687
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
16. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
17. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
19. Effects of high dietary fat and cholesterol on expression of PPAR alpha, LXR alpha, and their responsive genes in the liver of apoE and LDLR double deficient mice.
Zou Y; Du H; Yin M; Zhang L; Mao L; Xiao N; Ren G; Zhang C; Pan J
Mol Cell Biochem; 2009 Mar; 323(1-2):195-205. PubMed ID: 19067122
[TBL] [Abstract][Full Text] [Related]
20. MIF and D-DT are potential disease severity modifiers in male MS subjects.
Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]